Location History:
- Long Yan, CN (2015 - 2016)
- Fujian, CN (2015 - 2018)
Company Filing History:
10 out of 11 
1 out of 1 Years Active: 2015-2018
Title: **Hongxi Lai: Innovator in Natural Medicine**
Introduction
Hongxi Lai is a prominent inventor based in Fujian, China, with a focus on developing innovative solutions in the field of natural medicine and medicinal chemistry. With a total of 11 patents to his name, Lai has made significant contributions to the pharmaceutical industry, particularly in the development of compounds that can be utilized for antitumor applications.
Latest Patents
Among his most recent patents, the first is titled "1-oxo/acylation-14-acylated oridonin derivative, preparation method therefor and application thereof." This invention pertains to the creation of a 1-oxo/acylated-14-acylated oridonin derivative, along with its preparation methods and applications in developing antitumor drugs.
His second latest patent, "2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof," introduces novel derivatives of tanshinone I. This invention focuses on the process of creating these compounds, their pharmaceutical compositions, and their uses in the preparation of antineoplastic medications.
Career Highlights
Hongxi Lai has worked with several reputable companies in the pharmaceutical sector, notably at Hangzhou Bensheng Pharmaceutical Co., Ltd. and Hangzhou Bensheng Pharmaceuticals Co., Ltd. His experience in these organizations has allowed him to apply his innovative ideas and contribute to important research in the field.
Collaborations
During his career, Lai has collaborated with talented individuals such as Rongzhen Xu and Frank Rong. These partnerships have combined their expertise and insights, leading to advancements in the development of medicinal compounds.
Conclusion
In conclusion, Hongxi Lai stands out as an innovative inventor whose work has implications for the future of natural medicine. With a strong portfolio of patents and collaborations with industry professionals, he continues to push the boundaries of pharmaceutical chemistry and contribute to essential healthcare solutions.